HomeVKTX • NASDAQ
add
Viking Therapeutics Inc
Previous close
$62.32
Year range
$8.28 - $99.41
Market cap
6.90B USD
Avg Volume
3.46M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 34.05M | 43.45% |
Net income | -22.25M | -15.73% |
Net profit margin | — | — |
Earnings per share | -0.20 | -5.26% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 942.26M | 139.81% |
Total assets | 946.84M | 136.30% |
Total liabilities | 25.86M | 77.38% |
Total equity | 920.98M | — |
Shares outstanding | 110.80M | — |
Price to book | 7.50 | — |
Return on assets | -8.89% | — |
Return on capital | -9.17% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -22.25M | -15.73% |
Cash from operations | -28.51M | -149.35% |
Cash from investing | -126.06M | 38.35% |
Cash from financing | 2.90M | -98.91% |
Net change in cash | -151.66M | -396.47% |
Free cash flow | -21.91M | -342.07% |
About
CEO
Founded
2012
Website
Employees
29
